{
  "num_tested_probands": 6,
  "num_positive_het_probands": 0,
  "positive_phenotypes": [],
  "num_compound_or_double_hets": 1,
  "explanation": {
    "num_tested_probands": [
      {
        "type": "EXPLICIT",
        "text": "The three probands of the three unrelated families were referred to DCRU because of prolonged duration of action of succinylcholine."
      },
      {
        "type": "INFERRED",
        "text": "The text mentions that some members had died and genotyping was not possible, suggesting that there may be additional individuals who underwent genetic testing."
      }
    ],
    "num_positive_het_probands": [
      {
        "type": "EXPLICIT",
        "text": null
      },
      {
        "type": "INFERRED",
        "text": "The text states that the proband in family 1 was heterozygous for BCHE*115D/I3E4-14C/BCHE*FS126, and the proband in family 3 was compound heterozygous for BCHE*328D and BCHE*142M. However, it does not explicitly state that these individuals are single-allele (monoallelic) pathogenic carriers."
      }
    ],
    "positive_phenotypes": [
      {
        "type": "EXPLICIT",
        "text": null
      },
      {
        "type": "INFERRED",
        "text": "The text states that the proband in family 1 had BChE activity below detection limit and experienced an extensively prolonged duration of action of succinylcholine. This suggests that this individual has a positive phenotype, but the exact phenotype is not specified."
      }
    ],
    "num_compound_or_double_hets": [
      {
        "type": "EXPLICIT",
        "text": null
      },
      {
        "type": "INFERRED",
        "text": "The text states that the proband in family 3 was compound heterozygous for BCHE*328D and BCHE*142M. This suggests that there is at least one individual who has two different pathogenic variants in the same gene."
      }
    ]
  }
}